<?xml version="1.0" encoding="UTF-8"?>
<ref id="B218-pharmaceuticals-14-00381">
 <label>218.</label>
 <element-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Mishra</surname>
    <given-names>L.</given-names>
   </name>
   <name>
    <surname>Itokawa</surname>
    <given-names>H.</given-names>
   </name>
   <name>
    <surname>Bastow</surname>
    <given-names>K.F.</given-names>
   </name>
   <name>
    <surname>Tachibana</surname>
    <given-names>Y.</given-names>
   </name>
   <name>
    <surname>Nakanishi</surname>
    <given-names>Y.</given-names>
   </name>
   <name>
    <surname>Kilgore</surname>
    <given-names>N.</given-names>
   </name>
   <name>
    <surname>Lee</surname>
    <given-names>K.-H.</given-names>
   </name>
   <name>
    <surname>Sinha</surname>
    <given-names>R.</given-names>
   </name>
  </person-group>
  <article-title>Anti-HIV and cytotoxic activities of Ru (II)/Ru (III) polypyridyl complexes containing 2, 6-(2â€²-benzimidazolyl)-pyridine/chalcone as co-ligand</article-title>
  <source>Biorg. Med. Chem.</source>
  <year>2001</year>
  <volume>9</volume>
  <fpage>1667</fpage>
  <lpage>1671</lpage>
  <pub-id pub-id-type="doi">10.1016/S0968-0896(01)00074-8</pub-id>
 </element-citation>
</ref>
